Following the functional in vitro studies on CAPE and Kaempferol, it was found that the two phytochemical compounds have an inhibitory effect on RKO and HCT-116 colon cancer cell lines and could be potentially used in the future to develop new alternative therapeutic strategies or complete the conventional treatment regimens for this malignancy. The gene discussed is SMC2; the disease is colonic neoplasm.